Zobrazeno 1 - 10
of 346
pro vyhledávání: '"Frank L.J. Visseren"'
Autor:
Daniël Duijzer, Maria A. de Winter, Marc Carrier, Alexander T. Cohen, John-Bjarne Hansen, Karin A.H. Kaasjager, Ajay K. Kakkar, Saskia Middeldorp, Henrik T. Sørensen, Frank L.J. Visseren, Philip S. Wells, Jannick A.N. Dorresteijn, Mathilde Nijkeuter
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 8, Iss 7, Pp 102569- (2024)
Background: After 3 months of anticoagulation for venous thromboembolism (VTE), the decision needs to be made whether to stop anticoagulation or extend treatment indefinitely. The VTE-PREDICT calculator can be used to estimate individual risks of VTE
Externí odkaz:
https://doaj.org/article/762594d3a38a49cfa6a9cbbcee03a280
Autor:
Jannick A.N. Dorresteijn, MD, PhD, MSc, Steven H.J. Hageman, MD, PhD, MSc, Frank L.J. Visseren, MD, PhD, Deepak L. Bhatt, MD, MPH, MBA
Publikováno v:
JACC: Advances, Vol 3, Iss 9, Pp 101089- (2024)
Externí odkaz:
https://doaj.org/article/c7e68e008bb7474da86264e622ea27d7
Publikováno v:
Atherosclerosis Plus, Vol 55, Iss , Pp 5-11 (2024)
Background and aims: – Pseudoxanthoma elasticum (PXE) is a rare genetic disease caused by pathogenic mutations in the ABCC6 gene, resulting in low values of inorganic pyrophosphate (PPi). While low PPi is thought to contribute to arterial calcifica
Externí odkaz:
https://doaj.org/article/6b633572d2964dc18c327a82fb03d3c1
Autor:
Kausik K. Ray, Inaam Haq, Aikaterini Bilitou, Marius C. Manu, Annie Burden, Carlos Aguiar, Marcello Arca, Derek L. Connolly, Mats Eriksson, Jean Ferrières, Ulrich Laufs, Jose M. Mostaza, David Nanchen, Ernst Rietzschel, Timo Strandberg, Hermann Toplak, Frank L.J. Visseren, Alberico L. Catapano
Publikováno v:
The Lancet Regional Health. Europe, Vol 29, Iss , Pp 100624- (2023)
Summary: Background: European data pre-2019 suggest statin monotherapy is the most common approach to lipid management for preventing cardiovascular (CV) events, resulting in only one-fifth of high- and very high-risk patients achieving the 2019 ESC/
Externí odkaz:
https://doaj.org/article/32912a0f3308464fa848f83c48aeb9b3
Autor:
Kausik K. Ray, Inaam Haq, Aikaterini Bilitou, Carlos Aguiar, Marcello Arca, Derek L. Connolly, Mats Eriksson, Jean Ferrières, Per Hildebrandt, Ulrich Laufs, Jose M. Mostaza, David Nanchen, Ernst Rietzschel, Timo Strandberg, Hermann Toplak, Frank L.J. Visseren, Alberico L. Catapano
Publikováno v:
Atherosclerosis Plus, Vol 43, Iss , Pp 24-30 (2021)
Background and aims: Clinical practice before 2019 suggests a substantial proportion of high and very high CV risk patients taking lipid-lowering therapy (LLT) would not achieve the new LDL-C goals recommended in the 2019 ESC/EAS guidelines (
Externí odkaz:
https://doaj.org/article/dbab45f4fb3240539a4e517d5daa6696
Autor:
Cilie C. van ’t Klooster, MD, Paul M. Ridker, MD, PhD, Nancy R. Cook, PhD, Joachim G.J.V. Aerts, MD, PhD, Jan Westerink, MD, PhD, Folkert W. Asselbergs, MD, PhD, Yolanda van der Graaf, MD, PhD, Frank L.J. Visseren, MD, PhD, F.W. Asselbergs, H.M. Nathoe, G.J. de Borst, M.L. Bots, M.I. Geerlings, M.H. Emmelot, P.A. de Jong, T. Leiner, A.T. Lely, N.P. van der Kaaij, L.J. Kappelle, Y. Ruigrok, M.C. Verhaar, J. Westerink
Publikováno v:
JACC. CardioOncology, Vol 2, Iss 3, Pp 400-410 (2020)
Background: Cardiovascular disease (CVD) and cancer share many common risk factors; patients with CVD also may be at risk of developing cancer. Objectives: The aim of this study was to derive and externally validate prediction models for the estimati
Externí odkaz:
https://doaj.org/article/39e1d6e7295343dc9dcb786f47207db0
Autor:
Cilie C. van 't Klooster, Hendrik M. Nathoe, J. Hjortnaes, Michiel L. Bots, Ivana Isgum, Nikolas Lessmann, Yolanda van der Graaf, Tim Leiner, Frank L.J. Visseren
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 27, Iss , Pp - (2020)
Aims: The aim is to investigate (multifocal) cardiovascular calcification in patients with established cardiovascular disease (CVD), regarding prevalence, risk factors, and relation with recurrent CVD or vascular interventions. Coronary artery calcif
Externí odkaz:
https://doaj.org/article/2ae8fbcbb05d496f81d89de318e5cf38
Publikováno v:
Journal of Lipid Research, Vol 58, Iss 11, Pp 2180-2187 (2017)
Familial dysbetalipoproteinemia (FD) is a genetic disorder associated with impaired postprandial lipid clearance. The effect of adding bezafibrate to standard lipid-lowering therapy on postprandial and fasting lipid levels in patients with FD is unkn
Externí odkaz:
https://doaj.org/article/2c82703b868a4cbdbd7acb52456fce6b
Autor:
Manon C. Stam‐Slob, Yolanda van der Graaf, Jacoba P. Greving, Jannick A.N. Dorresteijn, Frank L.J. Visseren
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 2 (2017)
BackgroundA validated prediction model estimates the absolute benefit of intensive versus standard lipid‐lowering therapy (LLT) with statins on next major cardiovascular events for individual patients with coronary artery disease. We aimed to asses
Externí odkaz:
https://doaj.org/article/fbb33fd68be64b34a70ece2de1298e1d
Autor:
Pascal M. Burger, Aruna D. Pradhan, Jannick A.N. Dorresteijn, Stefan Koudstaal, Martin Teraa, Gert J. de Borst, Manon G. van der Meer, Arend Mosterd, Paul M. Ridker, Frank L.J. Visseren
Publikováno v:
The American Journal of Cardiology. 197:13-23
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd40975232c775f9e6b408a6e7411c5b
https://doi.org/10.1016/j.amjcard.2023.03.025
https://doi.org/10.1016/j.amjcard.2023.03.025